Old Web
English
Sign In
Acemap
>
authorDetail
>
Zamkoff Kw
Zamkoff Kw
State University of New York Upstate Medical University
Medicine
Toxicity
Immunology
Recombinant DNA
Refractory
4
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II study of recombinant interleukin-2 with or without recombinant interferon-β in non-Hodgkin's lymphoma. A study of the cancer and leukemia group B
1992
Journal of Immunotherapy
David B. Duggan
Maria Teresa Santarelli
Zamkoff Kw
Stuart M. Lichtman
John Ellerton
Robert Cooper
Bernard J. Poiesz
James R. Anderson
Clara D. Bloomfield
Bruce A. Peterson
Arlan J. Gottlieb
Show All
Source
Cite
Save
Citations (21)
A phase I trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy
1992
Journal of Immunotherapy
Zamkoff Kw
Jane Hudson
Eric S. Groves
Anne Childs
Michael Konrad
Alfred R. Rudolph
Show All
Source
Cite
Save
Citations (26)
Phase I trial of recombinant interleukin-2 and recombinant beta-interferon in refractory neoplastic diseases.
1989
Journal of biological response modifiers
Frank P. Paolozzi
Zamkoff Kw
Doyle M
Michael Konrad
Edward C. Bradley
Alfred R. Rudolph
Newman Nb
John J. Gullo
Anthony J. Scalzo
Bernard J. Poiesz
Show All
Source
Cite
Save
Citations (11)
A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.
1989
Journal of biological response modifiers
Zamkoff Kw
Newman Nb
Alfred R. Rudolph
Young J
Bernard J. Poiesz
Show All
Source
Cite
Save
Citations (15)
1